Overview - The Centers for Medicare & Medicaid Services (“CMS”) has finalized and proposed several significant changes affecting ...

UnitedHealth reshapes its Medicare Advantage strategy, citing rising healthcare costs and internal financial pressures as key drivers for the shift.

AstraZeneca's efforts are paying off as strong U.S. demand, and robust sales of newer cancer, heart and kidney disease ...

Health Secretary Robert F. Kennedy Jr. is promoting his plan to “fix” the system that HHS uses to compensate people injured ...

A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in ...

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 20.2% in the morning session after the company ...

AstraZeneca ’s AZN second-quarter 2025 core earnings of $1.09 per American depositary share (ADS) came in line with the Zacks ...

A bill centered on prohibiting medical debt from appearing on consumer reports was signed into law by Gov. Matt Meyer.

AstraZeneca's (AZN) revenue hit a record high in the second quarter, driven by cancer drug sales and growth in the US market.

AstraZeneca PLC ( NASDAQ: AZN) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ET ...

Effective board governance in complex health systems requires structured approaches that cascade quality and safety ...

The Trump administration has gutted rules and programs meant to protect people from ever-increasing health care costs.